Study type

Study topic

Human medicinal product

Study type

Clinical trial

If ‘other’, further details on the scope of the study

Educational Intervention
Clinical trials

Clinical trial regulatory scope

Clinical trial not part of marketing authorisation application or subject to marketing authorisation approval

Clinical trial randomisation

Randomised clinical trial

Clinical trial types

Cluster randomised trial
Single-arm trial
Population studied

Short description of the study population

All pharmacists working during the period study in the community pharmacies were included in this study.

Age groups

Preterm newborn infants (0 – 27 days)
Term newborn infants (0 – 27 days)
Infants and toddlers (28 days – 23 months)
Children (2 to < 12 years)
Adolescents (12 to < 18 years)
Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

0
Study design details

Main study objective

To reduce antibiotics consumption in the community.

Outcomes

Overall antibiotics consumption. Six main subclasses of antibiotic consumption (tetracyclines, penicillins, cephalosporins, sulfonamides and trimethoprim, macrocodes, quinolones).

Data analysis plan

It was used monthly sales data for each community sourced from IMS Health® (for the period May 2012 to September 2014) and aggregated by active substance in accordance with the Anatomical Therapeutic Chemical (ATC). To evaluate the impact of the intervention the data were expressed as number of packages per 1000 inhabitants per day (PID).
Documents
Study publications
Roque F, Soares S, Breitenfeld L, López-Durán A, Figueiras A, Herdeiro MT. Atti…
Roque F, Soares S, Breitenfeld L, Figueiras A, Herdeiro MT. Influence of commun…
Roque F, Herdeiro MT, Soares S, Teixeira Rodrigues A, Breitenfeld L, Figueiras …
Roque F, Soares S, Breitenfeld L, Gonzalez-Gonzalez C, Figueiras A, Herdeiro MT…
Roque F, Teixeira-Rodrigues A, Breitenfeld L, Piñeiro-Lamas M, Figueiras A, Her…